{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T17:46:42Z","timestamp":1775065602965,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T00:00:00Z","timestamp":1676332800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T00:00:00Z","timestamp":1676332800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s12098-022-04469-6","type":"journal-article","created":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T11:14:04Z","timestamp":1676373244000},"page":"143-148","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Autoimmune Hemolytic Anemia in Children: Clinical Profile and Outcome"],"prefix":"10.1007","volume":"91","author":[{"given":"Shrutiprajna","family":"Kar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3781-8423","authenticated-orcid":false,"given":"C. G. Delhi","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakhee","family":"Kar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhishekh","family":"Basavarajegowda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,14]]},"reference":[{"key":"4469_CR1","doi-asserted-by":"crossref","unstructured":"Silberstein LE, Cunningham MJ. Autoimmune Hemolytic Anemias. In: Hillyer CD, Silberstein LE, Ness PM, Anderson KC, Roback JD, editors. Blood Banking and Transfusion Medicine. Basic Principles and Practice. 2nd ed. Philadelphia: Churchill Livingstone; 2007. p. 53\u20139.","DOI":"10.1016\/B978-0-443-06981-9.50046-6"},{"key":"4469_CR2","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/ajh.10062","volume":"69","author":"BC Gehrs","year":"2002","unstructured":"Gehrs BC, Friedberg RC. Autoimmune hemolytic anemia. Am J Hematol. 2002;69:258\u201371.","journal-title":"Am J Hematol."},{"key":"4469_CR3","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1182\/blood-2002-01-0087","volume":"100","author":"VM Moyo","year":"2002","unstructured":"Moyo VM, Smith D, Brodsky I, Crilley P, Jones RJ, Brodsky RA. High-dose cyclophosphamide for refractory autoimmune hemolytic anemia. Blood. 2002;100:704\u20136.","journal-title":"Blood."},{"key":"4469_CR4","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/00005792-194005000-00002","volume":"19","author":"W Dameshek","year":"1940","unstructured":"Dameshek W, Schwartz RS. Acute hemolytic anemia (acquired hemolytic icterus, acute type). Medicine. 1940;19:231\u2013327.","journal-title":"Medicine"},{"key":"4469_CR5","doi-asserted-by":"publisher","first-page":"4036","DOI":"10.1182\/blood-2011-05-347708","volume":"118","author":"M Crowther","year":"2011","unstructured":"Crowther M, Chan YL, Garbett IK, Lim W, Vickers MA, Crowther MA. Evidence-based focused review of the treatment of idiopathic warm immune hemolytic anemia in adults. Blood. 2011;118:4036\u201340.","journal-title":"Blood."},{"key":"4469_CR6","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1080\/08880010701360783","volume":"24","author":"R Naithani","year":"2007","unstructured":"Naithani R, Agrawal N, Mahapatra M, Kumar R, Pati HP, Choudhry VP. Autoimmune hemolytic anemia in children. Pediatr Hematol Oncol. 2007;24:309\u201315.","journal-title":"Pediatr Hematol Oncol."},{"key":"4469_CR7","doi-asserted-by":"crossref","unstructured":"Aladjidi N, Leverger G, Leblanc T, et al. Centre de R\u00e9f\u00e9rence National des Cytop\u00e9nies Auto-immunes de l'Enfant (CEREVANCE). New insights into childhood autoimmune hemolytic anemia: a French national observational study of 265 children. Haematologica. 2011;96:655\u201363.","DOI":"10.3324\/haematol.2010.036053"},{"key":"4469_CR8","doi-asserted-by":"crossref","unstructured":"Fan J, He H, Zhao W, et al. Clinical features and treatment outcomes of childhood autoimmune hemolytic anemia: a retrospective analysis of 68 cases. J Pediatr Hematol Oncol. 2016;38:e50\u20135.","DOI":"10.1097\/MPH.0000000000000476"},{"key":"4469_CR9","first-page":"58","volume":"82","author":"MC Oliveira","year":"2006","unstructured":"Oliveira MC, Oliveira BM, Murao M, Vieira ZM, Gresta LT, Viana MB. Clinical course of autoimmune hemolytic anemia: an observational study. J Pediatr (Rio J). 2006;82:58\u201362.","journal-title":"J Pediatr (Rio J)."},{"key":"4469_CR10","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/MPH.0000000000000897","volume":"39","author":"E Mantadakis","year":"2017","unstructured":"Mantadakis E, Farmaki E. Natural history, pathogenesis, and treatment of evans syndrome in children. J Pediatr Hematol Oncol. 2017;39:413\u20139.","journal-title":"J Pediatr Hematol Oncol."},{"key":"4469_CR11","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s12098-008-0071-0","volume":"75","author":"V Gupta","year":"2008","unstructured":"Gupta V, Shukla J, Bhatia BD. Autoimmune hemolytic anemia. Indian J Pediatr. 2008;75:451\u20134.","journal-title":"Indian J Pediatr."},{"key":"4469_CR12","doi-asserted-by":"crossref","unstructured":"Petz LD, Garratty G. Unusual Aspects of Acquired Immune Hemolytic Anemias. In: Petz LD, Garratty G, editors. Immune Hemolytic Anemias. 2nd ed. Philadelphia: Churchill Livingston; 2004. p. 319\u2013334.","DOI":"10.1016\/B978-0-443-08559-8.50013-3"},{"key":"4469_CR13","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1159\/000438960","volume":"42","author":"A Salama","year":"2015","unstructured":"Salama A. Clinically and\/or serologically misleading findings surrounding immune hemolytic anemias. Transfus Med Hemother. 2015;42:311\u20135.","journal-title":"Transfus Med Hemother."},{"key":"4469_CR14","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1056\/NEJM197107292850503","volume":"285","author":"BC Gilliland","year":"1971","unstructured":"Gilliland BC, Baxter E, Evans RS. Red-cell antibodies in acquired hemolytic anemia with negative antiglobulin serum tests. N Engl J Med. 1971;285:252\u20136.","journal-title":"N Engl J Med."},{"key":"4469_CR15","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1182\/blood-2014-06-583021","volume":"124","author":"W Barcellini","year":"2014","unstructured":"Barcellini W, Fattizzo B, Zaninoni A, et al. Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients. Blood. 2014;124:2930\u20136.","journal-title":"Blood."},{"key":"4469_CR16","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1046\/j.1537-2995.1990.30891020331.x","volume":"30","author":"RJ Sokol","year":"1990","unstructured":"Sokol RJ, Hewitt S, Booker DJ, Bailey A. Red cell autoantibodies, multiple immunoglobulin classes, and autoimmune hemolysis. Transfusion. 1990;30:714\u20137.","journal-title":"Transfusion."},{"key":"4469_CR17","volume-title":"Immune Hemolytic Anemias","author":"LD Petz","year":"2004","unstructured":"Petz LD, Garratty G. Management of Autoimmune Hemolytic Anemias. In: Petz LD, Garratty G, editors. Immune Hemolytic Anemias. 2nd ed. Philadelphia: Churchill Livingston; 2004. p. 401\u2013458","edition":"2"},{"key":"4469_CR18","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1080\/08880010490514778","volume":"21","author":"F Ozsoylu","year":"2004","unstructured":"Ozsoylu F. Megadose methylprednisolone for the treatment of patients with Evans syndrome. Pediatr Hematol Oncol. 2004;21:739\u201340.","journal-title":"Pediatr Hematol Oncol."},{"key":"4469_CR19","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/bjh.14627","volume":"177","author":"S Ducassou","year":"2017","unstructured":"Ducassou S, Leverger G, Fernandes H, et al. Benefits of rituximab as a second-line treatment for autoimmune hemolytic anemia in children: a prospective French cohort study. Br J Haematol. 2017;177:751\u20138.","journal-title":"Br J Haematol."},{"key":"4469_CR20","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/pbc.21264","volume":"50","author":"A Rao","year":"2008","unstructured":"Rao A, Kelly M, Musselman M, et al. Safety, efficacy, and immune reconstitution after rituximab therapy in pediatric patients with chronic or refractory hematologic autoimmune cytopenias. Pediatr Blood Cancer. 2008;50:822\u20135.","journal-title":"Pediatr Blood Cancer."},{"key":"4469_CR21","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/j.1365-2141.2005.05496.x","volume":"129","author":"VK Rao","year":"2005","unstructured":"Rao VK, Dugan F, Dale JK, et al. Use of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndrome. Br J Haematol. 2005;129:534\u20138.","journal-title":"Br J Haematol."},{"key":"4469_CR22","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1046\/j.1365-2141.2002.03430.x","volume":"117","author":"J Howard","year":"2002","unstructured":"Howard J, Hoffbrand AV, Prentice HG, Mehta A. Mycophenolate mofetil for the treatment of refractory autoimmune hemolytic anemia and autoimmune thrombocytopenic purpura. Br J Haematol. 2002;117:712\u20135.","journal-title":"Br J Haematol."},{"key":"4469_CR23","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.1600-0609.2005.00437.x","volume":"75","author":"R Kotb","year":"2005","unstructured":"Kotb R, Pinganaud C, Trichet C, et al. Efficacy of mycophenolate mofetil in adult refractory autoimmune cytopenias: a single center preliminary study. Eur J Haematol. 2005;75:60\u20134.","journal-title":"Eur J Haematol."},{"key":"4469_CR24","first-page":"64","volume":"29","author":"PW Collins","year":"1992","unstructured":"Collins PW, Newland AC. Treatment modalities of autoimmune blood disorders. Semin Hematol. 1992;29:64\u201374.","journal-title":"Semin Hematol."}],"container-title":["Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-022-04469-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12098-022-04469-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-022-04469-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T03:08:22Z","timestamp":1705460902000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12098-022-04469-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,14]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["4469"],"URL":"https:\/\/doi.org\/10.1007\/s12098-022-04469-6","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,14]]},"assertion":[{"value":"3 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Narayanan Parameswaran, Professor & Head, Department of Pediatrics, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The study was approved by the Institute Ethics committee (Human Studies); approval number - IEC\/JIPMER\/2018\/0255.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed consent was obtained from all the individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Patients signed informed consent regarding publishing their data.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"None.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}